An update on feline infectious peritonitis: virology and immunopathogenesis
Oral BPC-157 We use the oral formulation primarily when trying to influence gut-specific healing, including: Stomach ulcers Gut wall permeability Crohns disease Ulcerative colitis Celiac disease Post-infectious diarrhea Microscopic colitis We may also consider oral BPC-157 when conditions appear to be influenced by gut inflammation, including psoriasis, rosacea, mood disorders, and cognitive changes
Archives of pharmacal research, 30, 834-839
When combined, these peptides are frequently explored in advanced in-vitro and biochemical model systems to better understand coordinated peptide signaling, multi-pathway cellular regulation, and molecular interactions related to tissue-associated research models
Disease Management and Clinical Outcomes , 1, 136-141
Evans et al